Alzheimer's Disease as Type 3 Diabetes: The Impact of Insulin Resistance and the Therapeutic Potential of Semaglutide in Cognitive Decline
While initial evidence is encouraging, long-term safety, optimal dosage, and impact on AD progression remain unclear. If proven effective, semaglutide could serve as a dual-purpose drug, addressing both metabolic dysfunction and neurodegeneration.
Authors
- Deepesh Khanna (ORCID: https://orcid.org/0000-0002-8673-8297)
- A. Singh
- Monica Kumar
- Kirpal Bains
- Isha Verma
Institutions
- Nova Southeastern University (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70855_103762
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00